The Curebest™ 95GC Breast is a research assay service that measures gene expression in breast cancer tissue using a microarray in ER-positive N0 * 4 breast cancer cases (however, cases not receiving preoperative hormone therapy / chemotherapy). The report describes the expression level of each gene by 95 probes and the 95GC classification result (H or L) * 5.